What can be done to prevent congenital toxoplasmosis?
There is a great deal of confusion within the medical and lay communities regarding Toxoplasma infection in the pregnant woman. Many physicians are not aware of the significance of this infection in pregnant women or of measures that may decrease the likelihood of the birth of an infant with congenital toxoplasmosis. Data regarding the morbidity, incidence, cost, and measures for the prevention of congenital toxoplasmosis are discussed.
D000906:Antibodies / Q000032:analysis; D003362:Cost-Benefit Analysis; D004519:Education, Special / Q000191:economics; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008605:Mental Health Services / Q000191:economics; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000276:immunology; D014123:Toxoplasmosis / Q000276:immunology*; D014125:Toxoplasmosis, Congenital / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control*; D014481:United States
D000906:Antibodies